Report
Aromatase inhibitors in female breast cancer
Report documents
-
Executive summary of the final report
Aromatase inhibitors in female breast cancer
-
Final report
Aromatase inhibitors in female breast cancer
-
Documentation and evaluation of comments on the preliminary report
Aromatase inhibitors in female breast cancer
-
Executive summary of the preliminary report
Aromatase inhibitors in female breast cancer
-
Preliminary report
Aromatase inhibitors in female breast cancer
-
Report plan version 1.0
Aromatase inhibitors in female breast cancer
-
Documentation and evaluation of comments on the preliminary report plan
Aromatase inhibitors in female breast cancer
-
Preliminary report plan
Aromatase inhibitors in female breast cancer
Press releases
Aromatase inhibitors for breast cancer: advantages over tamoxifen in early-stage disease
Longer survival, later recurrences / Evidence for late-stage disease much poorer
Project details
- Project no.
- A10-03
- Commission
- Commission awarded on 19.07.2010 by the Federal Joint Committee (GBA).
- Report type
- Report
- Status
- Commission completed
- Department/Division
- Drug Assessment
- Topic
- Cancer